arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

PMGC Holdings Inc.

ELAB Health Care Biotechnology: Pharmaceutical Preparations
$2.66
▼ -5.3% Today
as of Oct 22, 16:48 ET
Last 30 days -42.42% Sep 14 → Oct 22
$2.49 $3.11 $3.74 $4.37 $4.99 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$2.69
High
$2.77
Low
$2.64
Volume
$5,168
Avg Vol
$270,859
Mkt Cap
$3M
P/E (TTM)
—
Beta
—
52w High
$1,538.40
52w Low
$2.58
Div Yield
—
Shares Out
$6M

Recent Press Releases & News last 60 days · 7 items

▸ Show all 7 press releases & news Free account →

ELAB earnings at a glance

Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±3.0% on average; after the most recent report on May 14, 2026 it moved +4.0%. The share price of $2.66 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.58
$1.5K
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+3.0%
100% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-11.21$-8.42$-5.64$-2.85$-0.07 Actual $-0.11Actual $-0.13Actual $-0.08Actual $-0.08Actual $-0.08Actual $-0.07Actual $-2.90Actual $-0.46Actual $-4.95Actual $-11.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-5M$-3M$-2M$-212,859$1M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-11.21 — — -286.6% +4.0% earnings
Fri Nov 14, 2025Sep/2025 $-4.95 — — — — earnings
Tue Aug 12, 2025Jun/2025 $-0.46 — — — — earnings
Wed May 14, 2025Mar/2025 $-2.90 — — — +2.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.07 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.08 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.08 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.08 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.13 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.11 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$681,994—$285,948———$527,478
Cost of revenue$920,919$451,520—$207,918———$133,577
Gross profit$385,691$230,474—$78,030———$393,901
Operating income———$-2M———$-625,615
Net income$-3M$-5M—$-3M$-562,355$-2M—$-2M
EPS (diluted)———————$-0.07

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$18M$14M$5M—————
Inventory$932,508$253,558$95,098$128,469———$986,421
Total current assets$21M$16M$7M$10M$7M$7M$6M$8M
Total assets$37M$26M$13M$15M$9M$9M$9M$11M
Long-term debt————————
Total liabilities$20M$13M$5M$6M$326,301$760,268$2M$3M
Total equity$17M$13M$8M$8M$9M$8M$7M$9M

Implied volatility — last 90 days

No IV snapshots yet for ELAB.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

ELAB earnings FAQ

How does ELAB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.0%, up 2 times and down 0 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.